Congenital deafness is certainly one of the most common monogenic diseases in humans, but it is also one of the most genetically heterogeneous, which makes molecular diagnosis challenging in most cases. Whole-exome sequencing in two out of three Algerian siblings affected by recessively-inherited, moderate to severe sensorineural deafness allowed us to identify a novel splice donor site mutation (c.5272+1G>A) in the gene encoding α-tectorin, a major component of the cochlear tectorial membrane. The mutation was present at the homozygous state in the three affected siblings, and at the heterozygous state in their unaffected, consanguineous parents. To our knowledge, this is the first reported TECTA mutation leading to the DFNB21 form of hearing impairment among Maghrebian individuals suffering from congenital hearing impairment, which further illustrates the diversity of the genes involved in congenital deafness in the Maghreb.
Introduction
Deafness is the most common congenital sensory defect. In developed countries, it is diagnosed in 1 out of 500 newborns (1) (2) (3) . In about 70% of the cases, deafness is nonsyndromic, which means isolated (4) . Congenital deafness is almost exclusively inherited as a monogenic disease, but a great variety of genes can be involved. It has been estimated that about 80% of the genetic forms of early onset nonsyndromic deafness are autosomal recessive (DFNB) forms, and 20% are autosomal dominant (DFNA) forms (5) . Sixty DFNB genes and 32 DFNA genes have been identified so far, and many more remain to be discovered (Hereditary Hearing Loss Homepage: http://hereditaryhearingloss.org/). We report the identification of a new splice site mutation in the DFNB21 gene TECTA (6) , encoding αtectorin, in three Algerian siblings affected by prelingual, moderate to severe sensorineural deafness.
Patients and methods
This study was approved by the local ethics committee. Informed consent for genetic testing was obtained from the adult individuals or, in the case of minor individuals, from their parents.
Patients
Sixty-seven Algerian families with at least two members affected by prelingual bilateral deafness were recruited. Affected individuals underwent clinical examination, including puretone audiometry, in otolaryngology centers in Algiers, Algeria. In the vast majority of cases, deaf children were born to consanguineous normal-hearing parents, therefore indicating a DFNB form of deafness. Here, we report on such a family with three siblings affected by prelingual, moderate to severe, bilateral sensorineural hearing impairment ( Figure 1A ). All
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A C C E P T E D ACCEPTED MANUSCRIPT three affected individuals underwent pure-tone audiometry in a soundproof room, with recording of air-conduction and bone-conduction thresholds. Air-conduction pure-tone average (ACPTA) threshold in the conversational frequencies (0.5, 1, 2, and 4 kHz) was measured for each ear, and its value for the best ear was used to define the severity of deafness: mild (20 dB < ACPTA ≤ 39 dB), moderate (40 dB < ACPTA ≤ 69 dB), severe (70 dB < ACPTA ≤ 89 dB), or profound (≥ 90 dB). Temporal bone CT scan revealed no inner ear malformation. The affected siblings had begun to walk independently at the age of nine months, and did not have any balance problems. Clinical examination failed to detect additional symptoms indicating a syndromic form of deafness, and neither proteinuria nor hematuria was detected. Both parents did not show any sign of hearing impairment.
Exome sequencing and Sanger sequencing
Genomic DNA was extracted from blood samples, using the Promega Wizard Genomic DNA Purification Kit (Promega, Madison, MI, USA, Cat. # A1120). Whole-exome sequencing was performed as previously described (7) with minor modifications, using the SureSelect V5 capture kit (Agilent) and HiSeq 2000 sequencer (Illumina). Bioinformatics analysis of sequence data was based on the pipeline provided by Illumina (CASAVA 1.8), and the algorithm ELANDv2e (Malony alignment and multi-seed mismatch reducing artifact) was used for sequence alignment. To validate the TECTA mutation and study its segregation by the Sanger technique, specific primers were designed using Primer3
(http://bioinfo.ut.ee/primer3-0.4.0/). The sequences of the primers are available on request.
Results and discussion
Among the DFNB families without mutations identified in the promoter, non-coding and coding exons of GJB2, the gene most frequently involved in Mediterranean countries (8) (9) (10) ,
we selected a family based on the auditory phenotype of the three affected siblings (IV.1, IV.2, and IV.3), who were affected by prelingual, symmetric, moderate to severe hearing impairment, with audiograms showing down-sloping curves ( Figure 1C ). We did not detect mutations in LRTOMT, OTOF, and TMC1, three DFNB genes previously shown to be involved in Maghrebian populations (11) (12) (13) (14) , by Sanger sequencing of the coding exons in patient IV.1. We therefore carried out whole-exome sequencing on pooled genomic DNA from two affected siblings, as previously described (7) . All variants present in the dBSNP132, 1000 genomes, Exome Variant Server, and HapMap databases with a prevalence greater than 0.01% were excluded. As the parents were consanguineous, we hypothesized that the causal mutations in the affected siblings were present at the homozygous state. Using these filters, we identified a previously unreported missense mutation in ADAMTSL2, c.2305G>A
(p.Gly769Arg), which was predicted to be damaging by the MutationTaster, SIFT, and Figure   1B ). The segregation of the ADAMTSL2 missense mutation in this family was compatible with a causal role in the hearing impairment as the mutation was present at the homozygous state in the three affected siblings and at the heterozygous state in their normal-hearing parents. However, mutations of ADAMTSL2 cause geleophysic dysplasia characterized by short stature, abnormalities of the hands and feet, and distinct facial features (16) , but none of these clinical signs was present in any of the deaf siblings, thus indicating that the ADAMTSL2 sequence variant was a nonpathogenic rare polymorphism. We also excluded the BRI3BP mutation because the third affected child (IV.3) carried this mutation at the heterozygous state. By contrast, the TECTA mutation, predicted to suppress the splice donor site of intron 15 (Max Ent, NNsplice, Human Splicing Finder, and Genesplicer algorithms),
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was present at the homozygous state in the three affected siblings and at the heterozygous state in their parents, and it was not present in 120 Algerian control individuals. We therefore conclude that this mutation, which is expected to result in abnormal splicing of the TECTA mRNA, is responsible for the hearing impairment in this family.
TECTA consists of 23 exons. It encodes a 2155 amino acid secreted protein, α-tectorin, which is one of the main noncollagenous proteins of the cochlear tectorial membrane (17, 18) . This ribbon-like strip of extracellular matrix lies over the cochlear hair cells and is critical both for the mechanical amplification of sound stimuli by the outer hair cells and for their transmission to the inner hair cells, which are the genuine sensory cells (19, 20) . Targeted deletion of Tecta in mice results in a detachment of the tectorial membrane from the sensory epithelium (19) .
The protein is composed of a nidogen (NIDO)-like domain, a large zonadhesin (ZA) region containing three trypsin inhibitor-like (TIL) cysteine-rich domains, four C8 domains (with eight conserved cysteine residues), a von Willebrand factor type C (vWFC) and four von
Willebrand factor type D (vWFD) domains, and a zona pellucida (ZP) domain (21). The TECTA splice site mutation identified in the Algerian family is expected to result in a truncated protein of 1765 amino acids lacking the ZP domain ( Figure 1D ).
TECTA has been implicated both in autosomal dominant (DFNA) and autosomal recessive (DFNB) forms of deafness (6, 15 
